Saturday 17 October 2026
Export OM’s income statement to Excel — free account
Outset Medical, Inc.
Outset Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $119.5 million, up 5.09% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 6.73%, free cash flow fell 90.5% and total debt rose 4.20%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
3.94
0.14
−3.43%
Follow OM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 4 | 4 |
| (94.23%) | (106.20%) | (53.90%) | (60.09%) | ||
| (30.80%) | (30.23%) | (27.18%) | (27.97%) | ||
ROIC |
(74.83%) | (76.86%) | (80.83%) | (86.10%) | |
Return on Tangible Assets |
(37.65%) | (37.47%) | (36.84%) | (39.59%) | |
Average Days of Receivables |
100.20 | 86.55 | 78.60 | 90.54 | |
Free Cash Flow per Share |
(3.03) | (3.10) | (1.86) | (2.09) | |
Free Cash Flow |
(53.91) | (47.12) | (34.25) | (38.88) | |
Capital Expenditures |
(0.62) | (0.80) | (0.74) | (0.56) | |
| Other line items | |||||
Cash ROIC |
(12.94%) | (12.02%) | (9.37%) | (11.36%) | |
Accounts Receivable Turnover |
3.57 | 3.74 | 3.78 | 3.67 | |
Accounts Payable Turnover |
24.85 | 32.94 | 53.45 | 23.26 | |
Inventory Turnover |
1.35 | 1.36 | 1.32 | 1.38 | |
Average Days of Payables |
8.41 | 2.78 | 7.53 | 23.70 | |
Days of Inventory on Hand |
240.52 | 238.96 | 259.62 | 251.73 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
20.05% | 17.77% | 18.15% | 18.25% | |
Selling, General and Administrative Expense of Revenue |
76.74% | 77.19% | 79.66% | 79.57% | |
Share Based Compensation of Revenue |
13.74% | 13.07% | 13.69% | 12.98% | |
Interest Coverage |
(4.34) | (4.78) | (4.89) | (4.81) | |
Operating CF/Net income |
0.61 | 0.57 | 0.45 | 0.52 | |
Depreciation/Fixed assets |
0.44 | 0.45 | 0.39 | 0.35 | |
Capex/Depreciation |
(0.27) | (0.38) | (0.47) | (0.43) | |
Revenue per Share |
6.75 | 7.85 | 6.40 | 6.33 | |
Operating CF per Share |
(3.00) | (3.05) | (1.82) | (2.06) | |
Capex per Share |
(0.03) | (0.05) | (0.04) | (0.03) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 |
Columns are period end dates